140 related articles for article (PubMed ID: 15094050)
21. Spontaneous release of cysteine proteinases but not of pore-forming peptides by viable Entamoeba histolytica.
Leippe M; Sievertsen HJ; Tannich E; Horstmann RD
Parasitology; 1995 Dec; 111 ( Pt 5)():569-74. PubMed ID: 8559589
[TBL] [Abstract][Full Text] [Related]
22. Stimulation by target cell membrane lipid of actin polymerization and phagocytosis by Entamoeba histolytica.
Bailey GB; Day DB; Nokkaew C; Harper CC
Infect Immun; 1987 Aug; 55(8):1848-53. PubMed ID: 2886434
[TBL] [Abstract][Full Text] [Related]
23. Pore-forming peptide of Entamoeba histolytica. Significance of positively charged amino acid residues for its mode of action.
Andrä J; Leippe M
FEBS Lett; 1994 Oct; 354(1):97-102. PubMed ID: 7525351
[TBL] [Abstract][Full Text] [Related]
24. [Entamoeba histolytica proteins which participate in the adhesion to human erythrocytes].
Rodríguez MA; Valdéz A; Orozco E
Arch Invest Med (Mex); 1990; 21 Suppl 1():257-62. PubMed ID: 2136494
[No Abstract] [Full Text] [Related]
25. Pore-forming peptide of pathogenic Entamoeba histolytica.
Leippe M; Ebel S; Schoenberger OL; Horstmann RD; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7659-63. PubMed ID: 1881907
[TBL] [Abstract][Full Text] [Related]
26. Potency of amoebapores compared to that of other membrane-permeating peptides.
Andrä J; Berninghausen O; Leippe M
Arch Med Res; 1997; 28 Spec No():156-7. PubMed ID: 9033052
[No Abstract] [Full Text] [Related]
27. Genomic and proteomic approaches highlight phagocytosis of living and apoptotic human cells by the parasite Entamoeba histolytica.
Marion S; Guillén N
Int J Parasitol; 2006 Feb; 36(2):131-9. PubMed ID: 16386742
[TBL] [Abstract][Full Text] [Related]
28. Membrane binding requirements for the cytolytic activity of Leishmania amazonensis leishporin.
Castro-Gomes T; Almeida-Campos FR; Calzavara-Silva CE; da Silva RA; Frézard F; Horta MF
FEBS Lett; 2009 Oct; 583(19):3209-14. PubMed ID: 19737559
[TBL] [Abstract][Full Text] [Related]
29. Identification and functional characterization of EhClC-A, an Entamoeba histolytica ClC chloride channel located at plasma membrane.
Salas-Casas A; Ponce-Balderas A; García-Pérez RM; Cortés-Reynosa P; Gamba G; Orozco E; Rodríguez MA
Mol Microbiol; 2006 Feb; 59(4):1249-61. PubMed ID: 16430698
[TBL] [Abstract][Full Text] [Related]
30. Murine T-cell clones against Entamoeba histolytica: in vivo and in vitro characterization.
Denis M; Chadee K
Immunology; 1989 Jan; 66(1):76-82. PubMed ID: 15493266
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of the major cysteine proteinases by stable episomal transfection underlines the important role of EhCP5 for the pathogenicity of Entamoeba histolytica.
Tillack M; Nowak N; Lotter H; Bracha R; Mirelman D; Tannich E; Bruchhaus I
Mol Biochem Parasitol; 2006 Sep; 149(1):58-64. PubMed ID: 16753229
[TBL] [Abstract][Full Text] [Related]
32. Biochemical analysis of Entamoeba histolytica HM1 strain resistant to complement lysis.
Arias-Negrete S; Sabanero-López M; Villagómez-Castro JC
Arch Med Res; 1992; 23(2):135-7. PubMed ID: 1340276
[TBL] [Abstract][Full Text] [Related]
33. Entamoeba histolytica: cytolytic activity of cell - free trophozoite extracts upon CHO cells.
Vargas-Villarreal J; Said-Fernández S
Arch Invest Med (Mex); 1984; 15(1):1-12. PubMed ID: 6089684
[No Abstract] [Full Text] [Related]
34. Novel structural and functional findings of the ehFLN protein from Entamoeba histolytica.
Díaz-Valencia JD; Almaraz-Barrera Mde J; Jay D; Hernández-Cuevas NA; García E; González-De la Rosa CH; Arias-Romero LE; Hernandez-Rivas R; Rojo-Domínguez A; Guillén N; Vargas M
Cell Motil Cytoskeleton; 2007 Nov; 64(11):880-96. PubMed ID: 17705278
[TBL] [Abstract][Full Text] [Related]
35. Physical, structural, and functional properties of the beta1 integrin-like fibronectin receptor (beta1EhFNR) in Entamoeba histolytica.
Sengupta K; Hernández-Ramírez VI; Rosales-Encina JL; Mondragón R; Garibay-Cerdenares OL; Flores-Robles D; Javier-Reyna R; Pertuz S; Talamás-Rohana P
Infect Genet Evol; 2009 Sep; 9(5):962-70. PubMed ID: 19577014
[TBL] [Abstract][Full Text] [Related]
36. EhRho1, a RhoA-like GTPase of Entamoeba histolytica, is modified by clostridial glucosylating cytotoxins.
Majumder S; Schmidt G; Lohia A; Aktories K
Appl Environ Microbiol; 2006 Dec; 72(12):7842-8. PubMed ID: 17056697
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial and cytolytic polypeptides of amoeboid protozoa--effector molecules of primitive phagocytes.
Leippe M
Dev Comp Immunol; 1999; 23(4-5):267-79. PubMed ID: 10426421
[TBL] [Abstract][Full Text] [Related]
38. Further physicochemical characterization of the monocyte locomotion inhibition factor (MLIF) produced by Entamoeba histolytica.
Díaz-Guerra O; Rico G; Ladrón de Guevara O; Padilla P; García L; Kretschmer RR
Arch Med Res; 1992; 23(2):151-2. PubMed ID: 1340280
[TBL] [Abstract][Full Text] [Related]
39. The amoebapore superfamily.
Zhai Y; Saier MH
Biochim Biophys Acta; 2000 Sep; 1469(2):87-99. PubMed ID: 10998571
[TBL] [Abstract][Full Text] [Related]
40. A lysine- and glutamic acid-rich protein, KERP1, from Entamoeba histolytica binds to human enterocytes.
Seigneur M; Mounier J; Prevost MC; Guillén N
Cell Microbiol; 2005 Apr; 7(4):569-79. PubMed ID: 15760457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
